Back to Search Start Over

Tonix Pharmaceuticals Presented Poster of Tonmya(TM) for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024

Source :
GlobeNewswire. June 17, 2024
Publication Year :
2024

Abstract

Treatment with Tonmya(TM) (TNX-102 SL, sublingual cyclobenzaprine HCl) in Phase 3 RESILIENT study significantly reduced daily pain and demonstrated broad fibromyalgia symptom improvement, as demonstrated by significant improvement on the [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
GlobeNewswire
Publication Type :
News
Accession number :
edsgcl.798008257